Actelion selects its molecular drug targets on the basis of the established platforms of expertise, capabilities, technologies and the professionals at its research center. Actelion’s drug hunters all have the opportunity to suggest a new target and follow the evaluation process. Additional selection criteria which the proposed projects are required to demonstrate include:

• medical need
• therapeutic novelty
• pharmacology models
• clinical feasibility